Therapy News and Research

RSS

U.S. Department of Defense grants 'Impact Award' to explore therapeutic options against advanced prostate cancer

The U.S. Department of Defense has granted the "Impact Award" to explore new therapeutic options against advanced prostate cancer - scientifically known as castration-resistant or hormone therapy resistant prostate cancer- to a multidisciplinary team of researchers made up of the Prostate Cancer Clinical Research Unit of the Spanish National Cancer Research Center, led by David Olmos, the Prostate Cancer Translational Research Group of the Vall d'Hebron Institute of Oncology, led by Joaquín Mateo, and the Genetics and Solid Tumors Laboratory of the University of Washington, led by Colin Pritchard.

7 Nov 2018

Scientists investigate how broad-spectrum antibiotic therapy affects interaction of gut bacteria

The human gut is teeming with billions of beneficial bacteria. Therapies that use antibiotics often destroy most of them.

7 Nov 2018

Bilingual therapy is vital to improve language disorders in dual-language children, finds study

New research has found that providing bilingual therapy is vital to improving developmental language disorders in dual-language children.

7 Nov 2018

New nuclear medicine tracer could improve diagnosis, treatment of non-small cell lung cancer

Researchers have developed a new nuclear medicine tracer that could improve diagnosis and treatment of non-small cell lung cancer.

7 Nov 2018

Fish-rich and vegetarian diet may reduce hypertension-related heart disease symptoms

Elevated levels of trimethylamine N-oxide--a compound linked with the consumption of fish, seafood and a primarily vegetarian diet--may reduce hypertension-related heart disease symptoms.

7 Nov 2018

New immunotherapy screening prototype helps physicians to effectively target tumors

A new immunotherapy screening prototype developed by University of California, Irvine researchers can quickly create individualized cancer treatments that will allow physicians to effectively target tumors without the side effects of standard cancer drugs.

7 Nov 2018

New synthetic compound based on brain hormone holds promise for cancer treatment

A lab team led by Nobel Prize winner Dr. Andrew Schally at the Miami Veterans Affairs Healthcare System and the University of Miami showed that a synthetic compound based on a brain hormone spurred the growth of cancer cells in Petri dishes but enigmatically had the opposite effect in mice.

6 Nov 2018

Cases of acute flaccid myelitis on the rise say federal health officials

The cases of acute flaccid myelitis (AFM) – a polio like debilitating illness affecting children is still on the rise announced the health officials from the Center for Disease Control and Prevention (CDC) this Monday (5th November 2018).

5 Nov 2018

Trial shows fish-enriched diet may reduce childhood asthma symptoms

A study led by La Trobe University has shown that eating fish such as sardines, salmon and trout twice a week can reduce asthma symptoms in children.

5 Nov 2018

Engaging in musical activities can improve social communication skills of autistic children

Engaging in musical activities such as singing and playing instruments in one-on-one therapy can improve autistic children's social communication skills, improve their family's quality of life, as well as increase brain connectivity in key networks, according to researchers at Université de Montréal and McGill University.

5 Nov 2018

Vizient and Provista insist CMS to reassess approach to Medicare home infusion therapy benefits

Vizient, the largest member-driven health care performance improvement company in the country and its subsidiary Provista, a leading supply chain partner for non-acute health care delivery organizations, urge CMS to reconsider its approach to the Medicare home infusion therapy benefit to recognize the full array of services needed for home infusion therapy services.

5 Nov 2018

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

5 Nov 2018

Experts identify barriers to using stroke-preventing anticoagulants in Canada

International guidelines recommend direct oral anticoagulants over warfarin to prevent stroke for most patients with atrial fibrillation.

5 Nov 2018

Study: Mental health diagnosis and treatment are up, stigma is down among college students

Mental health diagnoses and treatment of college students increased substantially between 2007 and 2017. More than one-third of students reported a diagnosed condition in 2016-2017, according to a study published online today in Psychiatric Services in Advance.

5 Nov 2018

TGen and City of Hope announce letter of intent to develop new cell therapy manufacturing facility

City of Hope, a world-renowned independent cancer research and treatment center, and its affiliate, Translational Genomics Research Institute, have announced a letter of intent to develop a state-of-the-art cell therapy manufacturing facility in the Phoenix Metropolitan Area, a move that would improve the speed at which stem cell research and cancer treatment is delivered.

5 Nov 2018

Genetics can be used to predict schizophrenic patient's response to antipsychotic drugs

Genetics can be used to predict a patient's response to antipsychotic drug treatment for schizophrenia, according to a recent study by investigators at The Feinstein Institute for Medical Research. The findings were published online today in the American Journal of Psychiatry.

5 Nov 2018

Therapy News and Research

U.S. Department of Defense grants 'Impact Award' to explore therapeutic options against advanced prostate cancer

Scientists investigate how broad-spectrum antibiotic therapy affects interaction of gut bacteria

Bilingual therapy is vital to improve language disorders in dual-language children, finds study

New nuclear medicine tracer could improve diagnosis, treatment of non-small cell lung cancer

Fish-rich and vegetarian diet may reduce hypertension-related heart disease symptoms

New immunotherapy screening prototype helps physicians to effectively target tumors

New synthetic compound based on brain hormone holds promise for cancer treatment

Cases of acute flaccid myelitis on the rise say federal health officials

Trial shows fish-enriched diet may reduce childhood asthma symptoms

Engaging in musical activities can improve social communication skills of autistic children

Vizient and Provista insist CMS to reassess approach to Medicare home infusion therapy benefits

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Experts identify barriers to using stroke-preventing anticoagulants in Canada

Study: Mental health diagnosis and treatment are up, stigma is down among college students

TGen and City of Hope announce letter of intent to develop new cell therapy manufacturing facility

Genetics can be used to predict schizophrenic patient's response to antipsychotic drugs

Scientists create tiny, biodegradable scaffold to transplant stem cells and deliver drugs

Eating fish as part of diet can reduce asthma symptoms in children, shows trial

Low risk thyroid cancer patients can be treated with smaller amount of radiation, suggests study

Men with early prostate cancer choose lower survival odds to improve quality of life

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News